155 related articles for article (PubMed ID: 30194782)
1. Monitoring serum cytokeratin 19 fragment 21-1 to determine the efficacy of docetaxel chemotherapy in advanced extramammary Paget's disease.
Onishi M; Maeda F; Akasaka T; Amano H
J Dermatol; 2019 Mar; 46(3):e83-e84. PubMed ID: 30194782
[No Abstract] [Full Text] [Related]
2. Serum cytokeratin 19 fragment 21-1 and carcinoembryonic antigen combination assay as a biomarker of tumour progression and treatment response in extramammary Paget disease.
Nakamura Y; Tanese K; Hirai I; Amagai M; Kawakami Y; Funakoshi T
Br J Dermatol; 2019 Sep; 181(3):535-543. PubMed ID: 30791097
[TBL] [Abstract][Full Text] [Related]
3. Serum cytokeratin 19 fragment 21-1 is a useful tumor marker for the assessment of extramammary Paget's disease.
Kato J; Sumikawa Y; Hida T; Kamiya T; Horimoto K; Kamiya S; Sato S; Takahashi H; Sawada M; Yamashita T
J Dermatol; 2017 Jun; 44(6):666-670. PubMed ID: 28150330
[TBL] [Abstract][Full Text] [Related]
4. Single-agent taxane is useful in palliative chemotherapy for advanced extramammary Paget disease: a case series.
Kato M; Yoshino K; Maeda T; Nagai K; Oaku S; Hiura A; Fujisawa Y
Br J Dermatol; 2019 Oct; 181(4):831-832. PubMed ID: 30920650
[No Abstract] [Full Text] [Related]
5. Successful TS-1 monotherapy as the second-line treatment for advanced extramammary Paget's disease: A report of two cases.
Kato J; Hida T; Yamashita T; Kamiya S; Horimoto K; Sato S; Takahashi H; Sawada M; Yamada M; Uhara H
J Dermatol; 2018 Jan; 45(1):80-82. PubMed ID: 28891079
[TBL] [Abstract][Full Text] [Related]
6. Sequential use with imiquimod and surgery in extramammary Paget's disease.
Toledo F; Silvestre JF; Cuesta L; Ballester I; Latorre N; Monteagudo A
Dermatol Ther; 2012; 25(1):82-5. PubMed ID: 22591501
[TBL] [Abstract][Full Text] [Related]
7. Conservative management of extramammary paget disease with imiquimod.
Baiocchi G; Begnami MD; Fukazawa EM; Surima WS; Badiglian-Filho L; Costa FD; Oliveira RA; Faloppa CC; Kumagai LY; Soares FA
J Low Genit Tract Dis; 2012 Jan; 16(1):59-63. PubMed ID: 21964211
[TBL] [Abstract][Full Text] [Related]
8. Successful treatment of extramammary Paget's disease with S-1 and docetaxel combination chemotherapy.
Kawakita R; Fusumae T; Oda S; Takeuchi A; Takasugi A; Yoshida T
J Dermatol; 2018 Sep; 45(9):e252-e253. PubMed ID: 29572930
[No Abstract] [Full Text] [Related]
9. Serum cell-free DNA levels are a useful marker for extramammary Paget disease.
Mijiddorj T; Kajihara I; Tasaki Y; Otsuka-Maeda S; Sakamoto R; Sawamura S; Kanazawa-Yamada S; Egashira S; Inoue K; Makino K; Miyashita A; Aoi J; Igata T; Makino T; Masuguchi S; Fukushima S; Jinnin M; Morinaga J; Ikeda T; Ihn H
Br J Dermatol; 2019 Sep; 181(3):505-511. PubMed ID: 30706452
[TBL] [Abstract][Full Text] [Related]
10. Treatment of limited extent extramammary Paget's disease with 5 percent imiquimod cream.
Badgwell C; Rosen T
Dermatol Online J; 2006 Jan; 12(1):22. PubMed ID: 16638390
[TBL] [Abstract][Full Text] [Related]
11. Primary extramammary Paget's disease of the skin: treatment and survival.
Trofymenko O; Garcia V; Zeitouni NC
Int J Dermatol; 2018 Sep; 57(9):e76-e78. PubMed ID: 30133752
[No Abstract] [Full Text] [Related]
12. Successful treatment of metastatic extramammary Paget's disease with S-1 and docetaxel combination chemotherapy.
Matsushita S; Yonekura K; Mera K; Kawai K; Kanekura T
J Dermatol; 2011 Oct; 38(10):996-8. PubMed ID: 21972953
[No Abstract] [Full Text] [Related]
13. Trial of low-dose 5-fluorouracil/cisplatin therapy for advanced extramammary Paget's disease.
Kariya K; Tsuji T; Schwartz RA
Dermatol Surg; 2004 Feb; 30(2 Pt 2):341-4. PubMed ID: 14871231
[TBL] [Abstract][Full Text] [Related]
14. Complete response of extramammary Paget's disease with imiquimod and PDT: Report of two cases.
Apalla Z; Lallas A; Tsorova A; Nikolaidou C; Vakirlis E; Ioannides D; Sotiriou E
Photodermatol Photoimmunol Photomed; 2018 Jul; 34(4):273-275. PubMed ID: 29575126
[No Abstract] [Full Text] [Related]
15. A novel tumour marker RCAS1 in a case of extramammary Paget's disease.
Enjoji M; Noguchi K; Watanabe H; Yoshida Y; Kotoh K; Nakashima M; Watanabe T; Nakamuta M; Nawata H
Clin Exp Dermatol; 2003 Mar; 28(2):211-3. PubMed ID: 12653716
[TBL] [Abstract][Full Text] [Related]
16. A case of metastatic extramammary Paget's disease that responded to combination chemotherapy.
Yamazaki N; Yamamoto A; Wada T; Ishikawa M; Moriya Y; Nakanishi Y
J Dermatol; 1999 May; 26(5):311-6. PubMed ID: 10380432
[TBL] [Abstract][Full Text] [Related]
17. Imiquimod 5% cream as a therapeutic option for extramammary Paget's disease.
Sawada M; Kato J; Yamashita T; Yoneta A; Hida T; Horimoto K; Sato S; Uhara H
J Dermatol; 2018 Feb; 45(2):216-219. PubMed ID: 29115681
[TBL] [Abstract][Full Text] [Related]
18. Complete remission of advanced extramammary Paget's disease treated with docetaxel: a case report.
Nakamori R; Omoto Y; Yamanaka K; Habe K; Kurokawa I; Mizutani H
Clin Exp Dermatol; 2012 Mar; 37(2):194-5. PubMed ID: 22007941
[No Abstract] [Full Text] [Related]
19. [A case of cytokeratin 19 positive extramammary Paget's disease with pulmonary metastases].
Hamada K; Onuma N
Nihon Kokyuki Gakkai Zasshi; 2010 Mar; 48(3):204-9. PubMed ID: 20387524
[TBL] [Abstract][Full Text] [Related]
20. Case of metastatic extramammary Paget's disease treated with trastuzumab-biosimilar monotherapy after S-1 and docetaxel combination chemotherapy.
Kimura T; Akamatsu Y; Kajihara I; Fukushima S; Ihn H
J Dermatol; 2020 Jan; 47(1):e1-e2. PubMed ID: 31571250
[No Abstract] [Full Text] [Related]
[Next] [New Search]
